Latest News

Bausch Health And BHVI Announce Exclusive Global Licensing Agreement For Myopia Control Contact Lens

Second Exclusive License Strengthens Bausch + Lomb’s Global Research Focus on Myopia SYDNEY, Australia and LAVAL, Quebec, Oct. 15, 2020 – Bausch Health Companies Inc. (NYSE/TSX: BHC) (“Bausch Health”) and Bausch + Lomb, its leading global eye health business, along with BHVI, an Australian not-for-profit organization with an international focus on vision research, announced today that

Read More »

A Review of Peripheral Eye Length Measurement Techniques

Geetha Sravani, PhD Candidate BHVI Eye length (EL) is one of the major factors that determine the optical image quality and is also an important measure to track myopia onset and progression. In this regard, measurement of peripheral EL is equally important as the measurement of central or axial EL, as the periphery of the eye

Read More »

Our Purpose

We fulfil unmet needs in the ophthalmic space by innovating commercially relevant technologies through to feasibility.

We generate ideas.  We push the scientific envelope.  We solve problems.  We translate and communicate our knowledge. We look forward.

Our Values

Focused

We focus exclusively on research, development and ophthalmic sector support.

Innovative

We lead with industry, solving problems and creating technology. We bring new ideas to markets.

Dynamic

We focus on meeting unmet needs. We trial, test, learn, share and adapt. 

Collaborative​

We cannot achieve without each other; our team, our partners and our customers.

Copyright © Brien Holden Vision Institute (ABN 49 081 303 282) Brien Holden Vision Institute Foundation (ABN 86 081 872 586). All Rights Reserved.

Our site uses cookies. By continuing to use this website, you agree to their use. For more details, please check our Privacy Policy.